Lab to promote collaborative ventures between Belmont's School of Pharmacy and health care providers NASHVILLE, Tenn., July 1
NASHVILLE, Tenn., July 1 /PRNewswire/ -- Cumberland Emerging Technologies,
Inc. (CET) today announced that Belmont University has established the Belmont
School of Pharmacy Department of Pharmaceutical Sciences Laboratory at the CET
Life Sciences Center. The Life Sciences Center, which is located in downtown
Nashville, provides lab and office space, equipment and infrastructure to
early-stage biopharmaceutical ventures.
(Photo: http://www.newscom.com/cgi-bin/prnh/20080701/CLTU108 )
Belmont has leased the space to support research and service programs of
its School of Pharmacy. The primary objective of the lab is to provide dosage
form development, characterization and quality analysis. The school will work
with the pharmaceutical industry and local and regional health care providers
to meet previously unmet and emerging needs related to drug delivery.
The work being performed at the Life Sciences Center is designed to help
provide drug delivery solutions, which is unique to pharmacy practice and
which, until now, has not played a major role in middle Tennessee's robust
health care scene," said Dr. Andrew Webster, Chair and Professor of
Pharmaceutical Sciences at Belmont's School of Pharmacy. "By partnering with
CET, our faculty and students have access to a community of resources to
advance research that will help drug developers bring their products to
patients who need them most."
"We are delighted to welcome Belmont School of Pharmacy to our growing
roster of tenants at the Life Sciences Center," said A.J. Kazimi, Chief
Executive Officer of Cumberland Pharmaceuticals and CET. "Partnering with
outstanding academic research and training programs like this one is a key
component of CET's strategy, and we look forward to providing laboratory and
equipment infrastructure to support their promising research."
Belmont's School of Pharmacy announced last week that it has received
approval from The Accreditation Council for Pharmacy Education (ACPE) to seat
its first class of 75 students for the 2008-09 academic year.
Belmont University, host of the 2008 Town Hall Presidential Debate, is a
fast-growing community of nearly 4,800 students who come from almost every
state and more than 25 countries. Committed to being a leader among teaching
universities, Belmont brings together the best of liberal arts and
professional education in a Christian community of learning and service.
Belmont's purpose is to help students explore their passions and develop their
talents to meet the world's needs. With more than 75 areas of study, 12
master's programs and three doctoral degrees, there is no limit to the ways
Belmont University can expand an individual's horizon. For more information,
visit www.belmont.edu.
Cumberland Emerging Technologies, Inc. (www.cet-fund.com) is a joint
initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University and
the Tennessee Technology Development Corporation. The mission of CET is to
bring biomedical technologies and products conceived at Vanderbilt and other
regional research centers to the marketplace. CET helps manage the development
and commercialization process for select projects, and provides expertise on
intellectual property, regulatory, manufacturing and marketing issues that are
critical to successful new biomedical products. CET's Life Sciences Center,
located in Nashville, Tennessee, provides laboratory space, equipment and
infrastructure to early-stage life sciences companies.
SOURCE Cumberland Emerging Technologies, Inc.
